SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI of $0 in Q1 FY2026
Q1 FY2026 Accumulated OCI was $0.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Accumulated OCI vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Accumulated OCI amounts to 0.0% of total assets for SGP, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $21.71B USD | -1.5% | +3.8% | 69.2% | |
| Mar 2026 | CHF 30.1M CHF | +1639.0% | +134.1% | 12.4% | |
| Jun 2026 | $2.38M USD | -17.0% | — | 0.3% | |
| Mar 2026 | $802K USD | -13.1% | +6.9% | 0.3% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | -$67K USD | -546.7% | — | 0.0% | |
| Apr 2026 | -$6.78M USD | -20.9% | — | 1.5% | |
| Jun 2026 | -$1.22B USD | -2.3% | — | 8.8% | |
| Peer median (excluding SGP) | — | -13.1% | +6.9% | 0.3% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.